SK278500B6 - AN AGENT FOR MOTION SICKNESS PREVENTION This paten - Google Patents

AN AGENT FOR MOTION SICKNESS PREVENTION This paten Download PDF

Info

Publication number
SK278500B6
SK278500B6 SK9491-87A SK949187A SK278500B6 SK 278500 B6 SK278500 B6 SK 278500B6 SK 949187 A SK949187 A SK 949187A SK 278500 B6 SK278500 B6 SK 278500B6
Authority
SK
Slovakia
Prior art keywords
formula
methyl
composition
mixture
motion sickness
Prior art date
Application number
SK9491-87A
Other languages
English (en)
Slovak (sk)
Inventor
Gyorgy Bodo
Jozsef Knoll
Eva Somfai
Sandor Virag
Ferenc Zak
Original Assignee
Gyorgy Bodo
Jozsef Knoll
Eva Somfai
Sandor Virag
Ferenc Zak
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gyorgy Bodo, Jozsef Knoll, Eva Somfai, Sandor Virag, Ferenc Zak filed Critical Gyorgy Bodo
Publication of SK278500B6 publication Critical patent/SK278500B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
SK9491-87A 1986-12-19 1987-12-18 AN AGENT FOR MOTION SICKNESS PREVENTION This paten SK278500B6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU865338A HU197510B (en) 1986-12-19 1986-12-19 Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick

Publications (1)

Publication Number Publication Date
SK278500B6 true SK278500B6 (en) 1997-05-14

Family

ID=10970131

Family Applications (1)

Application Number Title Priority Date Filing Date
SK9491-87A SK278500B6 (en) 1986-12-19 1987-12-18 AN AGENT FOR MOTION SICKNESS PREVENTION This paten

Country Status (26)

Country Link
US (1) US4925878A (fi)
EP (1) EP0294441B1 (fi)
JP (1) JP2534553B2 (fi)
AT (1) ATE82847T1 (fi)
BG (1) BG51918A1 (fi)
CY (1) CY1740A (fi)
CZ (1) CZ277831B6 (fi)
DD (1) DD264851A5 (fi)
DE (1) DE3782935T2 (fi)
DK (1) DK464788A (fi)
ES (1) ES2009228A6 (fi)
FI (1) FI883837A0 (fi)
GE (1) GEP19970949B (fi)
GR (1) GR871953B (fi)
HK (1) HK105193A (fi)
HU (1) HU197510B (fi)
IL (1) IL84786A (fi)
LT (1) LT4007B (fi)
LV (1) LV10185B (fi)
MD (1) MD408C2 (fi)
MX (1) MX9203088A (fi)
PT (1) PT86406B (fi)
RU (1) RU1825314C (fi)
SK (1) SK278500B6 (fi)
UA (1) UA19281A1 (fi)
WO (1) WO1988004552A1 (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
CS269271B1 (en) * 1988-05-30 1990-04-11 Hajicek Josef Method of selegiline's hydrochloride production
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
US5744500A (en) 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
US5767164A (en) * 1991-04-04 1998-06-16 Innovations Foundation Use of deprenyl to rescue damaged nerve cells
EP0578687A1 (en) * 1991-04-04 1994-01-19 The University Of Toronto Innovations Foundation Use of deprenyl to maintain, prevent loss, or recover nerve cell function
HUT63579A (en) * 1991-12-20 1993-09-28 Chinoin Gyogyszer Es Vegyeszet Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
US5242950A (en) * 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
ES2149850T3 (es) * 1993-05-04 2000-11-16 Ceva Sante Animale Utilizacion de la selegilina en medicina veterinaria.
FR2704756B1 (fr) * 1993-05-04 1995-07-28 Sanofi Elf Utilisation de la sélégiline en médecine vétérinaire.
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
DE69520430T2 (de) 1994-06-03 2001-10-18 Jmde Trust Newton Meta substituierte arylalkylamine und therapeutische und diagnostische verwendung davon
US6033682A (en) * 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
US6299901B1 (en) 1995-01-13 2001-10-09 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6348208B1 (en) 1995-01-13 2002-02-19 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6319954B1 (en) 1995-01-13 2001-11-20 Somerset Pharmaceuticals, Inc. S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions
WO1996024346A1 (en) * 1995-02-10 1996-08-15 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
DE69628415T3 (de) * 1995-03-02 2008-06-26 R.P. Scherer Technologies, Inc., Paradise Valley Arzneimittel enthaltend monoaminooxidase-b-hemmer
DE19716905C1 (de) * 1997-04-22 1998-08-27 Iip Inst Fuer Ind Pharmazie Fo Stabile, wäßrige Lösung auf der Grundlage von Selegilin und Vorrichtung zu ihrer Verabreichung
US6042533A (en) * 1998-07-24 2000-03-28 Kania; Bruce Apparatus and method for relieving motion sickness
US6197329B1 (en) 1999-05-03 2001-03-06 Drugtech Corporation Anti-nausea compositions and methods
US6443913B1 (en) 2000-03-07 2002-09-03 Bruce Kania Apparatus and method for relieving motion sickness
US6497649B2 (en) * 2001-01-21 2002-12-24 University Of Washington Alleviating motion, simulator, and virtual environmental sickness by presenting visual scene components matched to inner ear vestibular sensations
US7128705B2 (en) * 2002-11-26 2006-10-31 Artis Llc Motion-coupled visual environment for prevention or reduction of motion sickness and simulator/virtual environment sickness
AT16235U1 (de) * 2018-06-21 2019-04-15 Dr Reinhart Jarisch Kaugummi enthaltend Vitamin C

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1227447B (de) * 1962-03-30 1966-10-27 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Phenylisopropylaminen
GB1031425A (en) * 1962-03-30 1966-06-02 Chinoin Gyogyszer Es Vegyeszet New aralkylamines and their preparation
EP0564802B1 (de) 1992-04-10 1996-10-09 Schott Glaswerke Blei- und bariumfreies Kristallglas mit hoher Lichttransmission

Also Published As

Publication number Publication date
ATE82847T1 (de) 1992-12-15
LV10185B (en) 1995-04-20
MX9203088A (es) 1992-07-01
CZ277831B6 (en) 1993-06-16
JPH01501626A (ja) 1989-06-08
BG51918A1 (en) 1993-11-15
CY1740A (en) 1995-10-20
EP0294441A1 (en) 1988-12-14
LT4007B (en) 1996-07-25
PT86406B (pt) 1990-11-20
FI883837A (fi) 1988-08-18
UA19281A1 (uk) 1997-12-25
DD264851A5 (de) 1989-02-15
HUT45196A (en) 1988-06-28
DK464788D0 (da) 1988-08-18
CS8709491A1 (en) 1990-05-14
HU197510B (en) 1989-04-28
LV10185A (lv) 1994-10-20
US4925878A (en) 1990-05-15
JP2534553B2 (ja) 1996-09-18
MD408C2 (ro) 1996-07-31
IL84786A (en) 1991-08-16
GR871953B (en) 1988-04-19
RU1825314C (ru) 1993-06-30
EP0294441B1 (en) 1992-12-02
LTIP1849A (en) 1995-08-25
PT86406A (en) 1988-01-01
DE3782935D1 (de) 1993-01-14
GEP19970949B (en) 1997-03-31
DE3782935T2 (de) 1993-04-08
DK464788A (da) 1988-08-18
FI883837A0 (fi) 1988-08-18
HK105193A (en) 1993-10-15
ES2009228A6 (es) 1989-09-16
WO1988004552A1 (en) 1988-06-30

Similar Documents

Publication Publication Date Title
SK278500B6 (en) AN AGENT FOR MOTION SICKNESS PREVENTION This paten
US5538992A (en) Potentiation of drug response
US4937267A (en) Method of treatment of obesity
JP5094720B2 (ja) サブスタンス関連障害を処置する方法
JP2003521498A (ja) ストレス治療用の組成物
EP0077723B1 (fr) Composition pharmaceutique à action antagoniste périphérique des narcotiques
EP0146363A2 (en) Synergistic pharmaceutical compositions, their production and use
US6552087B1 (en) Therapeutic agent comprising (+)-sibutramine
EP1099446B1 (en) Combination for treating depression and anxiety containing a CNS-penetrant NK-1 receptor antagonist and an antidepressant or anxiolytic agent
US5270341A (en) Method of treatment or prophylaxis of depression and stress
JP2005502677A (ja) 新規なピペリジン―２，６−ジオン重硫酸塩類及びストレス関連情動性疾患を治療・処置するためにこれらを使用する方法。
JP2005538146A (ja) 新規なピペリジン―２，６−ジオンパモエート塩類及びストレス関連情動性疾患を治療・処置するためにこれらを使用する方法
US5945455A (en) Amine and amidine containing compounds as weight reducing agents
Dwivedi et al. CAFEEINE: AN IMPORTANT COMPONENT OF OUR DAILY METABOLISM
EP0135402B1 (fr) Antagonistes périphériques des opiacés, procédé d'obtention et compositions pharmaceutiques les contenant
US4188404A (en) Treatment of symptoms of aging
JPH03271223A (ja) ナフトキサジン類の新用途
JP2005015417A (ja) 抗疲労組成物
US4232021A (en) Anti-depressant methods
JP2024514347A (ja) Ｊａｋ３／ｊａｋ１／ｔｂｋ１選択的阻害剤を含む医薬組成物及びその医薬用途
KR20210135833A (ko) 실리비닌을 유효성분으로 함유하는 외상 후 스트레스장애 예방 또는 치료용 조성물
EP0113632A1 (fr) Procédé de préparation d'halométhylates de levallorphan et compositions pharmaceutiques antagonistes périphériques des opiacés en contenant
WO1999064006A1 (en) Use of a nk-1 receptor antagonist for treating psychiatric disorders